The change of some cytokine levels during immune-checkpoint inhibitor treatment in R/M head and neck cancer patients

被引：0
|
作者：
Komatsu, Nobukazu [1 ,2 ]
Ono, Takeharu [3 ]
Yokomizo, Kanako [2 ]
Yamada, Akira [2 ]
Umeno, Hirohito [3 ]
机构：
[1] Kurume Univ, Dept Immunol, Sch Med, Kurume, Japan
[2] Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Japan
[3] Kurume Univ, Sch Med, Dept Otolaryngol, Kurume, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2201
引用
收藏
页码：1409 / 1409
页数：1
相关论文
共 50 条
  • [1] Microfluidic isolation of immune cell-derived extracellular vesicles in head and neck cancer patients on immune-checkpoint blockade
    Levy, Andrew R.
    Torres, Daniel A. Ruiz
    Paithankar, Uma
    Ahmad, Raheel
    Rabe, Daniel C.
    Faden, Daniel L.
    Stott, Shannon L.
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [2] Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
    Wang, Zhenghang
    Liu, Chang
    Bai, Yuezong
    Zhao, Xiaochen
    Cui, Longgang
    Peng, Zhi
    Zhang, Xiaotian
    Wang, Xicheng
    Zhao, Zhengyi
    Li, Jian
    Shen, Lin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
    Zhang, Chenyue
    Zhang, Chenxing
    Wang, Haiyong
    CANCER LETTERS, 2023, 562
  • [4] Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma
    Ji, Jun Ho
    Ha, Sang Yun
    Lee, Danbi
    Sankar, Kamya
    Koltsova, Ekaterina K.
    Abou-Alfa, Ghassan K.
    Yang, Ju Dong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [5] Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade
    Wang, Wei
    Lozar, Taja
    Golfinos, Athena E.
    Lee, Denis
    Gronski, Ellery
    Ward-Shaw, Ella
    Hayes, Mitchell
    Bruce, Justine Y.
    Kimple, Randall J.
    Hu, Rong
    Harari, Paul M.
    Xu, Jin
    Keske, Aysenur
    Sondel, Paul M.
    Fitzpatrick, Megan B.
    Dinh, Huy Q.
    Lambert, Paul F.
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2953 - 2968
  • [6] A Case of Successful Treatment with an Immune Checkpoint Inhibitor after Head and Neck Photoimmunotherapy
    Hanyu, Kenji
    Okamoto, Isaku
    Tokashiki, Kunihiko
    Tsukahara, Kiyoaki
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 169 - 174
  • [7] Efficacy of Chemotherapy After Immune Checkpoint Inhibitor Discontinuation in Head and Neck Cancer
    Fukuoka, Osamu
    Saito, Yuki
    Mukai, Toshiyuki
    Hayashi, Takaaki
    Yamamura, Koji
    Sakai, Toshihiko
    Kobayashi, Kenya
    Akashi, Ken
    Yoshida, Masafumi
    Ando, Mizuo
    Yamasoba, Tatsuya
    LARYNGOSCOPE, 2024, 134 (01): : 228 - 235
  • [8] Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
    Wang, Haiyang
    Mustafa, Abdulkadir
    Liu, Shixi
    Liu, Jun
    Lv, Dan
    Yang, Hui
    Zou, Jian
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] Nutritional needs in patients with recurrent/metastatic Head & Neck Cancer (R/M HNSCC) receiving immune checkpoint inhibitors (ICI)
    Brown, Teresa
    Camilleri, Belinda
    Bauer, Judy
    Nottage, Michelle
    Hughes, Brett G. M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 125 - 126
  • [10] Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma
    Ariyasu, Hiroyuki
    Inaba, Hidefumi
    Ota, Takayuki
    Yamaoka, Hiroyuki
    Furukawa, Yasushi
    Iwakura, Hiroshi
    Doi, Naotaka
    Yamamoto, Yuki
    Akamizu, Takashi
    IN VIVO, 2018, 32 (02): : 345 - 351
12345